These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 1560385)
1. In vivo modeling of the pharmacodynamic interaction between benzodiazepines which differ in intrinsic efficacy. Mandema JW; Kuck MT; Danhof M J Pharmacol Exp Ther; 1992 Apr; 261(1):56-61. PubMed ID: 1560385 [TBL] [Abstract][Full Text] [Related]
2. In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil. Mandema JW; Tukker E; Danhof M J Pharmacol Exp Ther; 1992 Jan; 260(1):36-44. PubMed ID: 1309878 [TBL] [Abstract][Full Text] [Related]
3. Modeling of the effect site equilibration kinetics and pharmacodynamics of racemic baclofen and its enantiomers using quantitative EEG effect measures. Mandema JW; Heijligers-Feijen CD; Tukker E; De Boer AG; Danhof M J Pharmacol Exp Ther; 1992 Apr; 261(1):88-95. PubMed ID: 1560387 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic-pharmacodynamic modeling of the electroencephalographic effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity. Mandema JW; Sansom LN; Dios-Vièitez MC; Hollander-Jansen M; Danhof M J Pharmacol Exp Ther; 1991 Apr; 257(1):472-8. PubMed ID: 1850477 [TBL] [Abstract][Full Text] [Related]
5. Mechanism-based pharmacodynamic modeling of the interaction of midazolam, bretazenil, and zolpidem with ethanol. Tuk B; van Gool T; Danhof M J Pharmacokinet Pharmacodyn; 2002 Jun; 29(3):235-50. PubMed ID: 12449497 [TBL] [Abstract][Full Text] [Related]
6. Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration-EEG effect relationship. Mandema JW; Kuck MT; Danhof M Br J Pharmacol; 1992 Jan; 105(1):164-70. PubMed ID: 1350744 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats: assessment of rapid functional adaptation. Cox EH; Kuipers JA; Danhof M Br J Pharmacol; 1998 Aug; 124(7):1534-40. PubMed ID: 9723968 [TBL] [Abstract][Full Text] [Related]
8. Modelling of the pharmacodynamics and pharmacodynamic interactions of CNS active drugs. Danhof M; Mandema JW Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):516-9. PubMed ID: 1490817 [TBL] [Abstract][Full Text] [Related]
9. Mechanism-based modeling of the pharmacodynamic interaction of alphaxalone and midazolam in rats. Visser SA; Huntjens DR; van der Graaf PH; Peletier LA; Danhof M J Pharmacol Exp Ther; 2003 Nov; 307(2):765-75. PubMed ID: 12975494 [TBL] [Abstract][Full Text] [Related]
10. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668 [TBL] [Abstract][Full Text] [Related]
11. Quantification of pharmacodynamic interactions between dexmedetomidine and midazolam in the rat. Bol CJ; Vogelaar JP; Tang JP; Mandema JW J Pharmacol Exp Ther; 2000 Jul; 294(1):347-55. PubMed ID: 10871332 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: correlation with the interaction at the mu-opioid receptor. Cox EH; Kerbusch T; Van der Graaf PH; Danhof M J Pharmacol Exp Ther; 1998 Mar; 284(3):1095-103. PubMed ID: 9495871 [TBL] [Abstract][Full Text] [Related]
13. Adaptive changes in the pharmacodynamics of midazolam in different experimental models of epilepsy: kindling, cortical stimulation and genetic absence epilepsy. Cleton A; Voskuyl RA; Danhof M Br J Pharmacol; 1998 Oct; 125(4):615-20. PubMed ID: 9831893 [TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic model for acute tolerance development to the electroencephalographic effects of alfentanil in the rat. Mandema JW; Wada DR J Pharmacol Exp Ther; 1995 Dec; 275(3):1185-94. PubMed ID: 8531080 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic-pharmacodynamic characterization of the cardiovascular, hypnotic, EEG and ventilatory responses to dexmedetomidine in the rat. Bol CJJG ; Danhof M; Stanski DR; Mandema JW J Pharmacol Exp Ther; 1997 Dec; 283(3):1051-8. PubMed ID: 9399976 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic-pharmacodynamic modeling of electroencephalographic effects of midazolam in eight Chinese men. Lu JF; Chen G; Xiang BR; An DK Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):399-403. PubMed ID: 7717060 [TBL] [Abstract][Full Text] [Related]
17. Kinetics and EEG effects of midazolam during and after 1-minute, 1-hour, and 3-hour intravenous infusions. Greenblatt DJ; Ehrenberg BL; Culm KE; Scavone JM; Corbett KE; Friedman HL; Harmatz JS; Shader RI J Clin Pharmacol; 2004 Jun; 44(6):605-11. PubMed ID: 15145968 [TBL] [Abstract][Full Text] [Related]
18. Relevance of arteriovenous concentration differences in pharmacokinetic-pharmacodynamic modeling of midazolam. Tuk B; Herben VM; Mandema JW; Danhof M J Pharmacol Exp Ther; 1998 Jan; 284(1):202-7. PubMed ID: 9435179 [TBL] [Abstract][Full Text] [Related]
19. Apparent pA2 values of benzodiazepine antagonists and partial agonists in monkeys. Paronis CA; Bergman J J Pharmacol Exp Ther; 1999 Sep; 290(3):1222-9. PubMed ID: 10454498 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration. Mandema JW; Tukker E; Danhof M Br J Pharmacol; 1991 Mar; 102(3):663-8. PubMed ID: 1364836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]